Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Open filters
Search
Tags
Author
Aditi Singhai
Alison Sathe
Anders Vinther
Anne-Caroline Boillot
Barbara W. Unger
Barry Price
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Khushboo Agrawal
Mark Agostino
Michael de la Torre
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Scott Sherrill
Tashil Sharma
Subscribe to our Newsletter
Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.
Site Intelligence

Who Really Owns the 483? A Sponsor's Guide to Shared Accountability at CMOs

quality system
Site Intelligence

Why Dashboards Can’t Save You From Pharma Supply Risk

No items found.
Site Intelligence

What 2,400+ FDA 483s Reveal About Sterility Compliance

No items found.
Site Intelligence

Person-in-Plant, Done Right: A Practical Framework for Sponsors and CMOs

Inspections
Regulatory Intelligence

The Signals That Predict Supply Chain Disruption Before It Happens

case studies

Redica's Veeva RIM Integration Turns Regulatory Signals into Compliance Outcomes

Integrated Solutions
Site Intelligence

The F&E Wake-Up Call: Why Facilities & Equipment Is Now the Fastest Growing 483 Category

No items found.

FDA's One-Day Inspections in Context: What the RRA Era Already Taught Us

inspection prep
Product News

Redica and Veeva Training Solutions: What this Partnership Means for GxP Compliance

No items found.
Regulatory Intelligence

Navigating Japan's Regulatory Complexity: What Regulatory Intelligence Teams Need to Know

Regulatory Intelligence
Regulatory Affairs
Japan
Pharma
PMDA
Regulatory Intelligence

Your Quality Team Is Flying Half the Plane. Here’s What’s Missing.

No items found.
Regulatory Intelligence

Navigating Russia’s Fragmented Regulatory Landscape

Regulatory Intelligence
Regulatory Compliance
Global Inspection Coverage
Pharma
medical devices
Regulatory Intelligence

GMP Annex 1 Is Effective. Now Watch How Inspectors Are Actually Using It.

sterile manufacturing
Regulatory Intelligence
Inspection
Contamination
aseptic processing
Site Intelligence

The FDA’s First AI Warning: Over-Reliance Is a cGMP Violation

data
AI
AI-Powered
Company News

Redica Expands Global Inspection Coverage with New PMDA, Swissmedic, EMA, and MFDS Data

data
EMA
Global Inspection Coverage
Inspection Events
Korea MFDS
Product Insights

Redica MCP Gateway: Context Engineering Tools

Context Engineering
Data Sources
MCP Gateway
Redica AI
Post-Market Intelligence

FDA PreCheck Initiative Draws Strong Industry Reaction at Recent Stakeholder Meeting

API
Digital IT Teams
Financial Services
Trends

FDA Increased For-Cause Inspections Almost 250% in 2025

483
FDA
FDA inspection
For-cause
For-Cause Inspections